These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 25462435

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.
    Henaine-Berra A, Garcia-Aguirre G, Quiroz-Mercado H, Martinez-Castellanos MA.
    J AAPOS; 2014 Apr; 18(2):120-3. PubMed ID: 24698606
    [Abstract] [Full Text] [Related]

  • 23. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
    Tseng CC, Chen SN, Hwang JF, Lin CJ.
    J Pediatr Ophthalmol Strabismus; 2012 Aug 07; 49 Online():e41-3. PubMed ID: 22881829
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Reactivation of retinopathy of prematurity after bevacizumab injection.
    Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R.
    Arch Ophthalmol; 2012 Aug 07; 130(8):1000-6. PubMed ID: 22491394
    [Abstract] [Full Text] [Related]

  • 26. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
    Spandau U.
    Acta Ophthalmol; 2013 Mar 07; 91(2):e154. PubMed ID: 22989079
    [No Abstract] [Full Text] [Related]

  • 27. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab.
    Zhang Y, Jiang YR, Lu Q, Yin H, Tao Y.
    Retina; 2013 Mar 07; 33(3):613-20. PubMed ID: 23296045
    [Abstract] [Full Text] [Related]

  • 28. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
    Wu WC, Lien R, Liao PJ, Wang NK, Chen YP, Chao AN, Chen KJ, Chen TL, Hwang YS, Lai CC.
    JAMA Ophthalmol; 2015 Apr 07; 133(4):391-7. PubMed ID: 25569026
    [Abstract] [Full Text] [Related]

  • 29. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
    Lepore D, Quinn GE, Molle F, Baldascino A, Orazi L, Sammartino M, Purcaro V, Giannantonio C, Papacci P, Romagnoli C.
    Ophthalmology; 2014 Nov 07; 121(11):2212-9. PubMed ID: 25001158
    [Abstract] [Full Text] [Related]

  • 30. Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity.
    Kang HG, Kim TY, Han J, Han SH.
    Korean J Ophthalmol; 2019 Jun 07; 33(3):272-278. PubMed ID: 31179659
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
    Axer-Siegel R, Snir M, Ron Y, Friling R, Sirota L, Weinberger D.
    Retina; 2011 Jun 07; 31(7):1239-47. PubMed ID: 21555969
    [Abstract] [Full Text] [Related]

  • 34. Refractive outcome of intravitreal bevacizumab injection in comparison to spontaneous regression of retinopathy of prematurity (ROP).
    Etezad Razavi M, Shoeibi N, Hassanzadeh S, Kianmehr S, Bakhtiari E.
    Strabismus; 2020 Mar 07; 28(1):49-54. PubMed ID: 31790628
    [Abstract] [Full Text] [Related]

  • 35. The Process of Retinal Vascularization after Anti-VEGF Treatment in Retinopathy of Prematurity: A Comparison Study between Ranibizumab and Bevacizumab.
    Alyamaç Sukgen E, Çömez A, Koçluk Y, Cevher S.
    Ophthalmologica; 2016 Mar 07; 236(3):139-147. PubMed ID: 27682852
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity.
    Pawar N, Somyashree D, Meenakshi R, Maheshwari D, Mohideen S, Sithiq Uduman M.
    Indian J Ophthalmol; 2023 Jun 07; 71(6):2561-2568. PubMed ID: 37322680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.